文献速递类风湿关节炎脊柱关节炎系统性红斑狼疮

风湿病学未满足需求:2018年靶向治疗会议报告

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018.
PubMed 文献 · Ann Rheum Dis · 2019-02-02

第20届国际靶向治疗会议汇集逾100名风湿病学、免疫学、流行病学、分子生物学等领域专家,按疾病分组讨论过去一年进展并更新未满足需求。会议重申需更好理解疾病异质性、识别临床前状态以实现治疗与预防、以及实现疾病治愈,临床 care 层面改善合并症管理和以患者为中心的 care、可负担新药仍属未满足需求。

要点

  • 需更好理解各疾病内部异质性并识别临床前状态以治疗和预防高危人群。
  • 疾病治愈能力仍难以实现,可及且可负担的新型靶向治疗需求突出。
  • 临床 care 层面改善合并症管理和以患者为中心的 care 仍是未满足需求。

核心结论

  • 未满足需求集中在理解疾病异质性、识别临床前状态以治疗和预防、实现治愈,以及可及且可负担的新型靶向治疗。
  • 临床 care 层面,改善合并症管理和以患者为中心的 care 继续被视为未满足需求。

研究设计与样本

  • 第20届年度国际靶向治疗会议汇集逾100名风湿病学、免疫学、流行病学、分子生物学及其他 specialty 的 leading 基础科学家和临床研究者。
  • 会议设五个疾病特异性分组(类风湿关节炎、银屑病关节炎、中轴型脊柱关节炎、系统性红斑狼疮、结缔组织病)及一个跨越上述临床领域的基础科学免疫学组,每组20-30名按专长分配的专家。
  • 各分组专家回顾过去一年临床领域近期成果,并更新基础/转化科学、临床科学与治疗开发、临床 care 三个类别领域的未满足需求。

主要发现

  • 部分既往识别的需求取得进展,同时识别出新的需求并重申既往会议主题。
  • 重申主题包括需更好理解各疾病内部异质性、识别临床前疾病状态以治疗和预防高危人群、以及难以实现的疾病治愈能力。
  • 临床 care 领域,改善合并症管理和以患者为中心的 care 继续是未满足需求,并强调需要新的且可负担的治疗。
  • 新型且可及靶向治疗、疾病预防及最终治愈的未满足需求仍是风湿病学优先事项。

临床怎么用

  • 临床与研究应关注疾病异质性分层、临床前状态的识别与干预,以及合并症管理和以患者为中心的 care。
  • 推动可及且可负担的新型靶向治疗研发,并将疾病预防与治愈作为优先方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

To develop a comprehensive listing of the greatest unmet scientific and clinical needs in rheumatology. The 20th annual international Targeted Therapies meeting brought more than 100 leading basic scientists and clinical researchers in rheumatology, immunology, epidemiology, molecular biology and other specialties. During the meeting, breakout sessions were convened, consisting of five disease-specific groups with 20-30 experts assigned to each group based on expertise. Specific groups included rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, systemic lupus erythematosus, connective tissue diseases and a basic science immunology group spanning all of these clinical domains. In each group, experts were asked to consider recent accomplishments within their clinical domain in the last year and update the unmet needs in three categorical areas: basic/translational science, clinical science and therapeutic development, and clinical care. While progress was noted among some of previously identified needs, both new needs were identified and themes from prior meetings were re-iterated: the need for better understanding the heterogeneity within each disease, and for identifying preclinical states of disease allowing treatment and prevention of disease in those at risk, and the elusive ability to cure disease. Within the clinical care realm, improved comorbidity management and patient-centred care continue to be unmet needs, and the need for new and affordable therapeutics was highlighted. Unmet needs for new and accessible targeted therapies, disease prevention and ultimately cure remain a priority in rheumatology.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Winthrop KL, Weinblatt ME, Crow MK, et al. Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018. Ann Rheum Dis. 2019. PMID: 30712015. doi:10.1136/annrheumdis-2018-214280

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。